{
  "ticker": "VRTX",
  "year": 2023,
  "quarter": 2,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 51,
  "transactions": [
    {
      "id": 76540,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-06-15",
      "transaction_shares": "8603",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "65159"
    },
    {
      "id": 118570,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-06-15",
      "transaction_shares": "8603",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "65159"
    },
    {
      "id": 166425,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-06-15",
      "transaction_shares": "8603",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "65159"
    },
    {
      "id": 76558,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-05-30",
      "transaction_shares": "82",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "56556"
    },
    {
      "id": 76594,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-05-30",
      "transaction_shares": "289",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "6838"
    },
    {
      "id": 118589,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-05-30",
      "transaction_shares": "82",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "56556"
    },
    {
      "id": 118631,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-05-30",
      "transaction_shares": "289",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "6838"
    },
    {
      "id": 166448,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-05-30",
      "transaction_shares": "82",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "56556"
    },
    {
      "id": 166497,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2023-05-30",
      "transaction_shares": "289",
      "transaction_price": "329.82",
      "transaction_type": "S",
      "shares_after_transaction": "6838"
    },
    {
      "id": 76525,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-05",
      "transaction_shares": "708",
      "transaction_price": "349.38",
      "transaction_type": "S",
      "shares_after_transaction": "36683"
    },
    {
      "id": 76535,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-05",
      "transaction_shares": "422",
      "transaction_price": "350.03",
      "transaction_type": "S",
      "shares_after_transaction": "34888"
    },
    {
      "id": 118553,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-05",
      "transaction_shares": "708",
      "transaction_price": "349.38",
      "transaction_type": "S",
      "shares_after_transaction": "36683"
    },
    {
      "id": 118563,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-05",
      "transaction_shares": "422",
      "transaction_price": "350.03",
      "transaction_type": "S",
      "shares_after_transaction": "34888"
    },
    {
      "id": 166408,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-05",
      "transaction_shares": "708",
      "transaction_price": "349.38",
      "transaction_type": "S",
      "shares_after_transaction": "36683"
    },
    {
      "id": 166418,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-05",
      "transaction_shares": "422",
      "transaction_price": "350.03",
      "transaction_type": "S",
      "shares_after_transaction": "34888"
    },
    {
      "id": 76563,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-02",
      "transaction_shares": "4645",
      "transaction_price": "349.48",
      "transaction_type": "S",
      "shares_after_transaction": "43704"
    },
    {
      "id": 76611,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-02",
      "transaction_shares": "1411",
      "transaction_price": "350.32",
      "transaction_type": "S",
      "shares_after_transaction": "38302"
    },
    {
      "id": 118597,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-02",
      "transaction_shares": "4645",
      "transaction_price": "349.48",
      "transaction_type": "S",
      "shares_after_transaction": "43704"
    },
    {
      "id": 118649,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-02",
      "transaction_shares": "1411",
      "transaction_price": "350.32",
      "transaction_type": "S",
      "shares_after_transaction": "38302"
    },
    {
      "id": 166457,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-05-02",
      "transaction_shares": "4645",
      "transaction_price": "349.48",
      "transaction_type": "S",
      "shares_after_transaction": "43704"
    },
    {
      "id": 166518,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-05-02",
      "transaction_shares": "1411",
      "transaction_price": "350.32",
      "transaction_type": "S",
      "shares_after_transaction": "38302"
    },
    {
      "id": 76529,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Garber Alan M",
      "reporting_owner_cik": "0001312907",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "584",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6474"
    },
    {
      "id": 76547,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5208"
    },
    {
      "id": 76579,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "2726"
    },
    {
      "id": 76584,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5318"
    },
    {
      "id": 76623,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1449",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 118557,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Garber Alan M",
      "reporting_owner_cik": "0001312907",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "584",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6474"
    },
    {
      "id": 118578,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5208"
    },
    {
      "id": 118615,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "2726"
    },
    {
      "id": 118621,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5318"
    },
    {
      "id": 118664,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1449",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 166412,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Garber Alan M",
      "reporting_owner_cik": "0001312907",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "584",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "6474"
    },
    {
      "id": 166435,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5208"
    },
    {
      "id": 166479,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "2726"
    },
    {
      "id": 166486,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1168",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5318"
    },
    {
      "id": 166534,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "1449",
      "transaction_price": null,
      "transaction_type": "D",
      "shares_after_transaction": "1435"
    },
    {
      "id": 76639,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-04-27",
      "transaction_shares": "1611",
      "transaction_price": "338.69",
      "transaction_type": "S",
      "shares_after_transaction": "128358"
    },
    {
      "id": 118681,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-04-27",
      "transaction_shares": "1611",
      "transaction_price": "338.69",
      "transaction_type": "S",
      "shares_after_transaction": "128358"
    },
    {
      "id": 166551,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-04-27",
      "transaction_shares": "1611",
      "transaction_price": "338.69",
      "transaction_type": "S",
      "shares_after_transaction": "128358"
    },
    {
      "id": 42998,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 43024,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 76585,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 76615,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 118622,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 118655,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 166487,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-12",
      "transaction_shares": "874",
      "transaction_price": "325.70",
      "transaction_type": "S",
      "shares_after_transaction": "46406"
    },
    {
      "id": 166524,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-12",
      "transaction_shares": "21300",
      "transaction_price": "72.14",
      "transaction_type": "M",
      "shares_after_transaction": "62510"
    },
    {
      "id": 43027,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    },
    {
      "id": 76618,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    },
    {
      "id": 118658,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    },
    {
      "id": 166527,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2023-04-04",
      "transaction_shares": "211",
      "transaction_price": "314.22",
      "transaction_type": "S",
      "shares_after_transaction": "47591"
    }
  ]
}